Unaudited Condensed Consolidated Statements of Operations - USD ($) shares in Thousands, $ in Thousands		3 Months Ended		6 Months Ended
		Jun. 30, 2024	Jul. 02, 2023	Jun. 30, 2024	Jul. 02, 2023
Income Statement [Abstract]
Net revenue	[1]	$ 143,900	$ 173,413	$ 308,486	$ 354,321
Cost of revenue		112,077	119,113	228,426	239,639
Gross profit		31,823	54,300	80,060	114,682
Operating expenses:
Research and development		19,851	20,831	40,078	42,965
Sales and marketing		29,757	32,482	60,286	66,361
General and administrative		19,186	16,536	37,253	32,772
Litigation reserves, net		8,200	0	8,230	0
Restructuring and other charges		1,688	2,229	2,720	2,337
Total operating expenses		78,682	72,078	148,567	144,435
Loss from operations		(46,859)	(17,778)	(68,507)	(29,753)
Other income, net	[2]	2,713	7,999	5,563	9,405
Loss before income taxes		(44,146)	(9,779)	(62,944)	(20,348)
Provision for (benefit from) income taxes		1,029	(1,192)	881	(2,049)
Net loss		$ (45,175)	$ (8,587)	$ (63,825)	$ (18,299)
Net loss per share
Basic		$ (1.56)	$ (0.29)	$ (2.19)	$ (0.63)
Diluted		$ (1.56)	$ (0.29)	$ (2.19)	$ (0.63)
Weighted average shares used to compute net loss per share:
Basic		28,883	29,319	29,136	29,170
Diluted		28,883	29,319	29,136	29,170

[1] No individual foreign country represented more than 10% of the Company’s total net revenue in the periods presented.

[2] (1) Amounts included gain/(loss), net from derivatives not designated as hedging instruments of $0.6 million and $2.1 million, for the three and six months ended June 30, 2024, respectively, and $1.0 million and $0.9 million, for the three and six months ended July 2, 2023, respectively, and gain/(loss), net from litigation settlements of $6.0 million for the three and six months ended July 2, 2023, respectively.